Transcription factor TAFII250 promotes Mdm2-dependent turnover of p53

N. Allende-Vega, M. K. Saville, D. W. Meek

    Research output: Contribution to journalArticle

    18 Citations (Scopus)

    Abstract

    The p53 tumour suppressor is regulated mainly by Mdm2, an E3 ubiquitin ligase that promotes the ubiquitylation and proteasome-mediated degradation of p53. Many agents that induce p53 are inhibitors of transcription, suggesting that the p53 pathway can detect a signal(s) arising from transcriptional malfunction. Mdm2 associates with TAFII250, a component of the general transcription factor TFIID. Inactivation of TAFII250 in ts13 cells, which express a temperature-sensitive mutant of TAFII250, leads to the induction of p53 and cell cycle arrest. In the present study, we show that TAFII250 stimulates the ubiquitylation and degradation of p53 in a manner that is dependent upon Mdm2 and requires its acidic domain. Mechanistically, TAFII250 downregulates Mdm2 auto-ubiquitylation, leading to Mdm2 stabilization, and promotes p53-Mdm2 association through a recently defined second binding site in the acidic domain of Mdm2. These data provide a novel route through which TAFII250 can directly influence p53 levels and are consistent with the idea that the maintenance of p53 turnover is coupled to the integrity of RNA polymerase II transcription.
    Original languageEnglish
    Pages (from-to)4234-4242
    Number of pages9
    JournalOncogene
    Volume26
    Issue number29
    DOIs
    Publication statusPublished - 2007

    Fingerprint

    Ubiquitination
    Transcription Factors
    Transcription Factor TFIID
    General Transcription Factors
    Ubiquitin-Protein Ligases
    RNA Polymerase II
    Proteasome Endopeptidase Complex
    Cell Cycle Checkpoints
    Down-Regulation
    Binding Sites
    Maintenance
    Temperature
    Neoplasms

    Keywords

    • p53
    • Mdm2
    • TAFII250
    • Transcription factors
    • Ubiquitylation

    Cite this

    Allende-Vega, N., Saville, M. K., & Meek, D. W. (2007). Transcription factor TAFII250 promotes Mdm2-dependent turnover of p53. Oncogene, 26(29), 4234-4242. https://doi.org/10.1038/sj.onc.1210209
    Allende-Vega, N. ; Saville, M. K. ; Meek, D. W. / Transcription factor TAFII250 promotes Mdm2-dependent turnover of p53. In: Oncogene. 2007 ; Vol. 26, No. 29. pp. 4234-4242.
    @article{64c1f8c725d942fa879eefb104cdef28,
    title = "Transcription factor TAFII250 promotes Mdm2-dependent turnover of p53",
    abstract = "The p53 tumour suppressor is regulated mainly by Mdm2, an E3 ubiquitin ligase that promotes the ubiquitylation and proteasome-mediated degradation of p53. Many agents that induce p53 are inhibitors of transcription, suggesting that the p53 pathway can detect a signal(s) arising from transcriptional malfunction. Mdm2 associates with TAFII250, a component of the general transcription factor TFIID. Inactivation of TAFII250 in ts13 cells, which express a temperature-sensitive mutant of TAFII250, leads to the induction of p53 and cell cycle arrest. In the present study, we show that TAFII250 stimulates the ubiquitylation and degradation of p53 in a manner that is dependent upon Mdm2 and requires its acidic domain. Mechanistically, TAFII250 downregulates Mdm2 auto-ubiquitylation, leading to Mdm2 stabilization, and promotes p53-Mdm2 association through a recently defined second binding site in the acidic domain of Mdm2. These data provide a novel route through which TAFII250 can directly influence p53 levels and are consistent with the idea that the maintenance of p53 turnover is coupled to the integrity of RNA polymerase II transcription.",
    keywords = "p53, Mdm2, TAFII250, Transcription factors, Ubiquitylation",
    author = "N. Allende-Vega and Saville, {M. K.} and Meek, {D. W.}",
    note = "dc.publisher: Nature Publishing Group dc.description.sponsorship: Association for International Cancer Research Cancer Research UK",
    year = "2007",
    doi = "10.1038/sj.onc.1210209",
    language = "English",
    volume = "26",
    pages = "4234--4242",
    journal = "Oncogene",
    issn = "0950-9232",
    publisher = "Nature Publishing Group",
    number = "29",

    }

    Allende-Vega, N, Saville, MK & Meek, DW 2007, 'Transcription factor TAFII250 promotes Mdm2-dependent turnover of p53', Oncogene, vol. 26, no. 29, pp. 4234-4242. https://doi.org/10.1038/sj.onc.1210209

    Transcription factor TAFII250 promotes Mdm2-dependent turnover of p53. / Allende-Vega, N.; Saville, M. K.; Meek, D. W.

    In: Oncogene, Vol. 26, No. 29, 2007, p. 4234-4242.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - Transcription factor TAFII250 promotes Mdm2-dependent turnover of p53

    AU - Allende-Vega, N.

    AU - Saville, M. K.

    AU - Meek, D. W.

    N1 - dc.publisher: Nature Publishing Group dc.description.sponsorship: Association for International Cancer Research Cancer Research UK

    PY - 2007

    Y1 - 2007

    N2 - The p53 tumour suppressor is regulated mainly by Mdm2, an E3 ubiquitin ligase that promotes the ubiquitylation and proteasome-mediated degradation of p53. Many agents that induce p53 are inhibitors of transcription, suggesting that the p53 pathway can detect a signal(s) arising from transcriptional malfunction. Mdm2 associates with TAFII250, a component of the general transcription factor TFIID. Inactivation of TAFII250 in ts13 cells, which express a temperature-sensitive mutant of TAFII250, leads to the induction of p53 and cell cycle arrest. In the present study, we show that TAFII250 stimulates the ubiquitylation and degradation of p53 in a manner that is dependent upon Mdm2 and requires its acidic domain. Mechanistically, TAFII250 downregulates Mdm2 auto-ubiquitylation, leading to Mdm2 stabilization, and promotes p53-Mdm2 association through a recently defined second binding site in the acidic domain of Mdm2. These data provide a novel route through which TAFII250 can directly influence p53 levels and are consistent with the idea that the maintenance of p53 turnover is coupled to the integrity of RNA polymerase II transcription.

    AB - The p53 tumour suppressor is regulated mainly by Mdm2, an E3 ubiquitin ligase that promotes the ubiquitylation and proteasome-mediated degradation of p53. Many agents that induce p53 are inhibitors of transcription, suggesting that the p53 pathway can detect a signal(s) arising from transcriptional malfunction. Mdm2 associates with TAFII250, a component of the general transcription factor TFIID. Inactivation of TAFII250 in ts13 cells, which express a temperature-sensitive mutant of TAFII250, leads to the induction of p53 and cell cycle arrest. In the present study, we show that TAFII250 stimulates the ubiquitylation and degradation of p53 in a manner that is dependent upon Mdm2 and requires its acidic domain. Mechanistically, TAFII250 downregulates Mdm2 auto-ubiquitylation, leading to Mdm2 stabilization, and promotes p53-Mdm2 association through a recently defined second binding site in the acidic domain of Mdm2. These data provide a novel route through which TAFII250 can directly influence p53 levels and are consistent with the idea that the maintenance of p53 turnover is coupled to the integrity of RNA polymerase II transcription.

    KW - p53

    KW - Mdm2

    KW - TAFII250

    KW - Transcription factors

    KW - Ubiquitylation

    U2 - 10.1038/sj.onc.1210209

    DO - 10.1038/sj.onc.1210209

    M3 - Article

    VL - 26

    SP - 4234

    EP - 4242

    JO - Oncogene

    JF - Oncogene

    SN - 0950-9232

    IS - 29

    ER -